Michael Andreeff, M.D., Ph.D.
Professor of Medicine and Haas Chair in Genetics and Chief, Section of Molecular Hematology & Therapy at the U.T. M.D. Anderson Cancer Center.
Daniel G. Haller, M.D.
Professor of Medicine Emeritus, Abramson Cancer Center at the University of Pennsylvania Perelman School of Medicine at the University of Pennsylvania.
Herbert I. Hurwitz, M.D.
Associate Professor of Medicine of Duke University Medical Center, Co-Director of Duke GI Oncology Program at the Duke Comprehensive Cancer Center.
Alan F. List, M.D.
President & CEO of Moffitt Cancer Center and is a senior member in the Department of Malignant Hematology and the Experimental Therapeutics Program.
Peter O’Dwyer, M.D.
Professor of Medicine at the University of Pennsylvania School of Medicine, and Director of the Developmental Therapeutics Program at the Abramson Cancer Center of the University of Pennsylvania. He is also Vice Chairman of the Eastern Cooperative Oncology Group and Co-Chair of the Gastrointestinal Committee.
Atsushi Ohtsu, M.D., Ph.D.
Director of the Research Center for Innovative Oncology and Head of the Department of GI Oncology/Gastroenterology at the National Cancer Center Hospital East (NCCHE) in Japan.
Philip A. Philip, M.D., Ph.D., F.R.C.P.
Leader of the Multidisciplinary Team for Gastrointestinal Oncology at the Barbara Ann Karmanos Cancer Institute, and Professor at Wayne State University School of Medicine.
Eric Rowinsky, M.D.
Head of Research and Development, Chief Medical Officer, and Executive Vice President, Stemline Therapeutics, Inc. and an Adjunct Professor of Medicine at New York University School of Medicine. Cancer Drug Development Consultant at Oncodrugs.
Branimar I. Sikic, M.D.
Professor of Medicine (Oncology and Clinical Pharmacology) at Stanford University School of Medicine; Associate Director, Stanford Cancer Center, and Director, Clinical and Translational Research Unit, Stanford University.
Alan P. Venook, M.D.
Professor of Clinical Medicine, Division of Medical Oncology at the University of California, San Francisco and leads the Gastrointestinal Oncology clinical program at UCSF Medical Center.